Margin stability in health insurance plans

An insurance company told an oncologist that her cancer patient could no longer receive chemotherapy in the cancer center. The patient walked away from treatment entirely.   Banu Symington has practiced hematology-oncology in rural settings for more than 20 years. In May, the field was told three rollout vectors were coming. Within a week, two carriers acted. She appealed and was denied. Her finance manager offered to match the off-site price. The carrier refused to negotiate.   Three rollout vectors every healthcare leader should be tracking in their market right now:   1. Off-site infusion mandates. Chemotherapy is moved out of the hospital cancer center to an independent infusion suite, often staffed only by nurses, with no oncologist on the floor, no ER down the hall, no code team in the building. Infusion reactions can occur at any cycle.   2. White bagging. The carrier ships the drug directly to the hospital pharmacy with no margin retained. The line item that keeps rural cancer centers solvent disappears.   3. Brown bagging. The carrier ships cytotoxic drugs to the patient's home. The patient transports the medication to the infusion suite. Temperature control and chain of custody are no longer guaranteed.   The rollout is rural-first by design. Fewer physicians, fewer patients, less organized resistance. Once it scales rurally, the urban rollout follows. Medicare Advantage, administered by private insurance, is beginning to follow.   The economic mechanism is the part most leaders miss. Cancer centers do not break even on Medicare or Medicaid patients. The margin on privately insured patients subsidizes the operation. Strip that margin and the rural cancer center operates at a net loss and eventually closes. Access collapses by financial design, not by clinical decision.   Search "The Podcast by KevinMD" wherever you listen to podcasts.   If your organization has watched one of these three vectors land in the last year, what did the access cost look like for your patients?   #HealthcareLeadership #PatientAdvocacy #HealthcareReform #PhysicianAdvocacy #ThePodcastbyKevinMD

Only 4 in 10 Medicare Advantage plans were profitable for CY2024. That's down from over 6 in 10 in CY2020 and prior. --- Milliman's latest analysis of 435 #MedicareAdvantage Organizations (MAOs) shows a quick decline in profitability the last two years. Composite underwriting margins turned negative for the second year in a row, down to -0.7%, from +1.1% in 2023. That’s a nearly $3 billion loss on $423 billion in revenue. The news is worse for provider-sponsored plans (PSHPs). Aggregate losses deepened to -4.5%, compared to -2.8% last year. Nearly one in five PSHPs reported losses exceeding 20%. --- Here are the primary drivers covered in the paper: -Medical loss ratio (MLR) hit a 10-year high driven by rising inpatient and outpatient utilization. -CMS benchmark rates have flattened. -#StarRatings dropped, reducing bonus revenue and creating drug benefit volatility. -The Inflation Reduction Act began impacting plans, especially on the #PartD side. Administrative costs remain a challenge, especially for smaller or less efficient plans. The trends were more forgiving for larger plans. 45% of MAOs with over $1B in revenue still posted gains. However, only 40% of all MAOs achieved positive margins, down from ~60% just a few years ago. Some carriers have already exited the market. Others are dialing back benefits or raising member cost-sharing. --- The conclusion is similar to what I've covered in previous posts. There's a shift towards focusing less on growth and more on profitability. Plans will need to rethink growth strategy, pricing, and care management. How is your organization handling this pressure?

My focus last year has been doing deep research into healthcare topics, turning ideas into writing, and communicating complex stuff with visuals. One breakthrough: using Claude Code to build research agents that can hunt down obscure data (it's over for my opps). I've been tracking public disputes between hospitals and insurers. 𝟮𝟬𝟯 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗱𝗶𝘀𝗽𝘂𝘁𝗲𝘀 𝗳𝗿𝗼𝗺 𝟮𝟬𝟮𝟭-𝟮𝟬𝟮𝟱, 𝗮𝗳𝗳𝗲𝗰𝘁𝗶𝗻𝗴 𝟲.𝟱𝗠+ 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀. Over 2M are currently stuck out-of-network. The average person knows more about NBA contract disputes (where's LeBron going next season?!). But when insurance contracts fall apart, the consequences are bigger - notification letters, billing chaos, surprise bills, lost continuity of care. If you have diabetes, receive chemo, or are pregnant, these disputes loom over you. I built some agents to hunt down the disputes, then spent my holiday break manually verifying cases (yes, I'm a nerd). This used to take months of work for research analysts. Now anyone with curiosity can do it. Some patterns that predict outcomes:  • Systems with healthy margins (>4% operating margin) resolve disputes 63% of the time. Struggling systems? Only 42%.  • Market dominance works AGAINST compromise. High market share systems (>30%) resolve only 36% vs 53% for smaller players. If you're the only game in town, you can afford to stay out-of-network.  • Humana is 4-for-47 in public disputes (8.5% resolution rate). When they don't like terms, they walk - especially in Medicare Adv markets. This isn't the sexiest topic, but it matters. 𝗠𝘆 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻: 𝗱𝗶𝘀𝗽𝘂𝘁𝗲 𝘃𝗼𝗹𝘂𝗺𝗲 𝘁𝗿𝗲𝗻𝗱𝘀 𝘂𝗽 𝘀𝗵𝗮𝗿𝗽𝗹𝘆. 𝗠𝗼𝗿𝗲 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹𝘀 𝗴𝗼 𝗢𝗢𝗡. Post-COVID contracts are coming up for renewal, and both hospitals and insurers face margin pressure. I've shared the data on Airtable with dashboards. Links in comments. Let me know what I'm missing (especially 2021-2023).

6 of 7 major health insurers paid out more in medical claims from 2021-2025. They cut administrative staff to offset the costs. Providers absorbed that burden. Medical loss ratio (MLR) measures how much of every premium dollar goes to actual medical care. An MLR of 90% means 90 cents goes to care, 10 cents to everything else: salaries, buildings, technology, profit. From 2021-2025, 6 of 7 major insurers saw rising MLR trends. CVS/Aetna: +6.8 points. Biggest jump (86.0% → 92.8%). 1,000+ employees laid off since October 2023. 30% of prior authorizations automated by 2024. $20B investment in AI and digital systems. Margin compression = aggressive cost cuts. UnitedHealth: +6.5 points. 82.6% → 89.1%. Billions quarterly on AI and automation. Late 2025 deployment of AI-powered prior authorization tools. Largest insurer, largest absolute margin squeeze. Elevance Health: +5.8 points. 87.7% → 93.5%. Highest MLR in the industry. Keeps only 6.5% of premiums. Blue Cross/Blue Shield plans. Provider appeals volume up 140%. Humana: +4.0 points. 87.1% → 91.1%. Medicare Advantage-focused. Margin compression from older, higher-cost patients. Centene: +4.9 points. 87.8% → 92.7%. Medicaid-heavy. Revenue grew 41.5% to $167B but MLR climbed faster. Molina: +4.5 points. 86.8% → 91.3%. Medicaid specialist. Revenue grew 65.8% to $44.6B. Strong growth but rising MLR. Cigna: -1.9 points. Only decrease. 86.7% → 84.8%. Keeps 15.2% of premiums: more than double Elevance. $200M+ quarterly on digital health. Early automation = margin protection while others scrambled. Provider impact: Industry administrative costs hit $67.4B annually in 2025, up 6.2%. Prior authorization volume per physician grew from 39 requests weekly (2021) to 43 requests (2024). Processing averaged 3-14 days in 2021. From 2021-2025, all major carriers deployed widespread automation. CVS cut 1,000+ administrative jobs while automating 30% of prior authorizations. Same pattern across all seven: MLR pressure → staff cuts + automation → provider burden increased. 28.7% of Medicare Advantage denials get reversed on appeal. External appeals: 64-83%. When most denials get reversed, it means the initial denial shouldn't have happened. Automated systems flag more cases, but fewer staff are available to review them. Prior authorization burden falls heaviest on radiology and imaging. High authorization exposure, declining reimbursement, 3-4 week approval delays. Each authorization costs providers $11-20 in administrative expenses. Some imaging centers dedicate full-time staff just to managing prior auth queues.

Elevance Health Earnings Call Translation: What They Say vs. What They Mean ▪️ What they say: “2026 is a year of execution and repositioning.” ➡️ What they mean: Growth is no longer the priority. The priority is fixing margins by changing who we cover, where we operate, and what we are willing to pay for. ▪️ What they say: “We are acting decisively in the areas within our control to strengthen margins, reduce volatility, and improve the consistency of our performance.” ➡️ What they mean: The controllable levers are utilization management, claims payment rules, network design, and pricing. Those levers are being pulled harder. ▪️ What they say: “We view 2026 as a trough year. We expect our Medicaid operating margin to be approximately negative 1.75%.” ➡️What they mean: Medicaid rates do not reflect actual utilization. Losses are being tolerated temporarily, not structurally. ▪️ What they say: “We expect Medicare Advantage membership to decline in the high teens percentage range in 2026, reflecting deliberate portfolio actions.” ➡️ What they mean: Markets, products, and members that don’t meet margin thresholds are being exited by design. ▪️ What they say: “The actions we’ve taken… position us to deliver meaningful Medicare margin improvement to at least 2% in 2026.” ➡️ What they mean: Fewer members, higher profitability per member. Volume is being traded for margin. ▪️ What they say: “We remain disciplined in our pricing and are willing to walk away from lower or negative margin public sector business.” ➡️ What they mean: If employers or public entities can’t absorb the premium increase, coverage is optional. ▪️ What they say: “We are strengthening our analytics to identify outlier utilization and billing patterns… including claims review enhancements and payment accuracy initiatives.” ➡️ What they mean: More scrutiny, more edits, more denials, and more aggressive post-payment recovery — especially in high-cost categories. ▪️ What they say: “The levers available when rates don’t keep pace with trend are benefits, networks, premiums, and exiting geographies.” ➡️ What they mean: Affordability pressure will be resolved by reducing coverage, narrowing access, raising prices, or leaving markets. https://lnkd.in/evJGw77K

Regional plans continue to shed offerings. This time it's Baylor Scott & White Health Plan (BS&W) exiting both Medicaid and the ACA individual market in TX. BS&W notified regulators of its intent to exit the TX Medicaid Managed Care Program and discontinue Individual Marketplace plans by the end of 2026. They will continue to operate as a provider and accept these patients so it only affects the insurance side The scale of the impacted population is meaningful but not dominant in TX: • ~125,000 Medicaid members • ~100,000 ACA marketplace members • ~225,000 total lives • ~3.5% share of TX Medicaid • ~2.6% share of the TX ACA marketplace The financial profile of the health plan helps explain the move. The IRS Form 990 for the plan, covering 2022, shows approximately $730M in revenue and $723M in expenses, resulting in ~$7M of net income. That is roughly a 1% margin! More recent plan-level data is not clearly broken out publicly, but given market conditions, it would not surprise me if margins turned negative these last couple of years. The timing of BS&W's announcement aligns with structural changes across both of these markets. Medicaid has been under pressure since continuous enrollment ended. Enrollment declined, and the remaining population has higher acuity with greater healthcare needs, leading to higher utilization and rising pharmacy costs. The ACA marketplace is becoming more volatile heading into 2026. Enhanced subsidies expired, increasing what members have to pay. Early estimates show average subsidized premiums more than doubling. This raises the risk of enrollment churn and adverse selection, especially for smaller plans. BS&W operates a health system with more than $15B in annual revenue and over $1B in operating income. Against that, a low margin or negative margin insurance line is not competitive for investment. Their strategy of shedding Medicaid and ACA offerings makes perfect sense. I’m wondering if long term they’ll look to sell their health plan business like Providence wants to.

I may have made $40K as a new grad medical social worker. But in one ER shift → I influenced $30K–$50K in Medicare Advantage exposure. Not “feel-good value.” Risk-adjusted cost & revenue sensitivity. Here’s the math : ↳ 2 high-risk seniors stabilized → same-week follow-up 30-day readmit benchmark ≈ $15,200 If probability shifts 25% → 15% Δ ≈ ~$3K/member in expected cost Multiple high-risk cases → compounding expected value (Probability ≠ causality.) ↳ 1 dual eligible w/ unstable housing → connected to care management MA economics depend on: • RAF stability • Documentation integrity • Continuity of care Instability → missed follow-up → documentation gaps Documentation gaps → revenue sensitivity ↳ Documentation gaps corrected before chart close Fixing one chart ≠ fixing one chart. It reduces downstream risk exposure. Today, RADV policy has been finalized, challenged, litigated — But audit acceleration is real. Error sensitivity modeling is real. Unsupported documentation creates exposure. ↳ 1 behavioral escalation diverted from admission Inpatient behavioral stay: $10K–$20K+ Expected cost = probability × cost Shift probability ↓ → expected spend ↓ When I was on the frontlines, this wasn’t called “margin defense.” Now it is. In a world of intensified audit scrutiny: Social instability = financial volatility. If: • Follow-up ≠ tied to member ID • Severity ≠ supported with MEAT • Continuity fractures before capture → Revenue becomes vulnerable. Not because patients weren’t sick. Because the record couldn’t survive review. Social work has always been probability management. Now it’s margin defense. If you’re building audit-survivable social care infrastructure — You'll want to see what I'm working on at Pull.

Is your medical insurance portfolio in the UAE a sustainable asset or a rising liability? As we navigate 2026, the Loss Ratio remains the most critical health check for any insurance company or corporate health scheme. With medical inflation in the region projected to climb by over 11% this year, maintaining that "sweet spot" (typically between 70% and 85%) has never been more challenging. ⚠️ The Current Challenges in the UAE: - Expansion of Mandatory Coverage. - The "Silent" Margin Killer: Fraud, Waste, and Abuse (FWA) remain the leading cost drivers. - Lifestyle Disease Surge: Chronic conditions like diabetes and cardiovascular issues continue to drive the highest volume of high-value claims in the UAE. - The continuous introduction of high-cost innovative treatments. Maintaining a healthy ratio isn't just about raising premiums, it’s about smarter management. In addition to AI claims auditing, shifting to value based healthcare (VBHC), and investing in wellness and early detection programs, technical pricing is one of the strategic factors to maintain a good loss ratio. Moving away from "price wars" and toward data-backed underwriting that reflects the true risk of the group. A healthy Loss Ratio isn't just a win for the insurer; it ensures premium stability for the client and quality care for the member. In 2026, the winners will be those who treat data as their best medicine. #UAEInsurance #HealthInsurance #LossRatio #InsuranceTrends2026 #DubaiBusiness #HealthcareFinance #Underwriting

🚨 Medicare Advantage’s Margin Cliff? 🚨 This chart says it all. Despite a decade of volatility—Affordable Care Act cuts, tax reform boosts, and the COVID margin surge—2024 marks the first time in 15 years that Medicare Advantage industry margins drop below zero. 📉 From ~5% pre-ACA to negative margins today. For health plan leaders, this is more than just a blip—it’s a strategic inflection point: ✅ Is your organization built to thrive in a 0% margin environment? ✅ Are your risk adjustment and STARS strategies audit-proof? ✅ Are you making operational bets based on past margins that may never return? Medicare Advantage is still a growth engine—but it's no longer a guaranteed profit center. If your leadership team is still playing by 2020 rules, it's time for a reset. #MedicareAdvantage #HealthPlans #PayerStrategy #HealthcareMargins #ExecutiveSearch #HealthPlanLeadership #ValueBasedCare #CMS #HealthcareTransformation

One of the best ways to assess where the payer-provider dynamic stands is by looking at this ratio. It summarizes the claims expense to premiums received relationship. Let's dig in (hint... it isn't pretty). TLDR version- payers are spending more premiums on care, having lower profitability, and providers will see impacts in 2025 The CVS says the "Medical benefit ratio is calculated by dividing the Health Care Benefits segment’s health care costs by premium revenues and represents the percentage of premium revenues spent on medical benefits for the segment’s insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results." A higher ratio here means plans see lower profitability. If the driver is cost (numerator), usually that benefits providers. For providers who still receive a large percent of payments tied to fee for service, high utilization is good. We actually saw hospital/system margins rise in 2024. However, the levels seen in the graph aren't sustainable for the long-run. A low ratio is often beneficial to the plan but painful to the provider because less money is going to care or their is an imbalance to premiums received. Too low isn't good either. Ultimately the pendulum needs to find balance for everyone- the patient, the provider, and the payer. To improve this ratio, either expenses have to decrease, premiums have to increase, or both. Let's look at the drivers: Expense Reduction Expenses are driven by utilization of services and cost of services utilized. This means that to inflect change people need to either be healthier and seek care less or when they seek care it is at a cheaper point (i.e. urgent care vs. the ER). Decreasing utilization directly impacts providers because they invest heavily in people and infrastructure for care. Expenses can also be reduced by cutting payment rates to providers. Increase Premiums In plans where premiums are based on risk scores, this means increasing risk scores. If plans can't increase risk scores to drive revenues then they have to increase the premiums that individuals or companies pay. V28 has negatively impacted risk scores to the tune of about 3% but a lot of premiums aren't tied to risk scores. Getting documentation and billing right drives accurate premiums in risk products. Overall View 2024 was a very hard year for payers. Their challenges then spill over to frustrations by providers for denials and care delays (i.e. prior-auth volumes increasing). It also means that they exit unprofitable markets and constraining options for patients. I imagine this year we will see pain by providers from more painful contract negotiations and delays. Recognize that the landscape that healthcare operates is complex with a lot of stakeholders. Understanding the total view will help you succeed at your organization.